Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
- 31 January 2008
- journal article
- clinical trial
- Published by Elsevier BV in Neuropharmacology
- Vol. 54 (1), 235-243
- https://doi.org/10.1016/j.neuropharm.2007.06.021
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiformeBritish Journal of Cancer, 2006
- Novel functions of TIMPs in cell signalingCancer and Metastasis Reviews, 2006
- Mislocalization and unconventional functions of cellular MMPs in cancerCancer and Metastasis Reviews, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Anandamide inhibits adhesion and migration of breast cancer cellsExperimental Cell Research, 2005
- Molecular-pathological prognostic factors of gastric cancer: a reviewGastric Cancer, 2005
- Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in GliomasCancer Research, 2004
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002